Back to Search Start Over

Current perspectives on recurrent pituitary adenoma: The role and timing of surgery vs adjuvant treatment.

Authors :
Hayhurst C
Taylor PN
Lansdown AJ
Palaniappan N
Rees DA
Davies JS
Source :
Clinical endocrinology [Clin Endocrinol (Oxf)] 2020 Feb; Vol. 92 (2), pp. 89-97. Date of Electronic Publication: 2019 Nov 22.
Publication Year :
2020

Abstract

The clinical course of pituitary adenoma can be highly variable. Aggressive pituitary tumours may require multimodal therapy with multiple operations. Even standard pituitary adenomas exhibit relatively high long-term recurrence rates and delayed intervention is often required. The indications for revision surgery in the endoscopic era are expanding for both functioning and nonfunctioning tumours, including access to the cavernous sinus and intracranial compartments. Although revision surgery can be challenging, it has been demonstrated to be both safe and effective. The question of the use of early radiotherapy in pituitary adenoma remains controversial. Our increasing understanding of pituitary tumour biology facilitates individualized treatment and surveillance protocols, with early intervention in high-risk adenoma subtypes. In this review, we discuss the treatment options for recurring pituitary tumours and focus on the role of revision surgery.<br /> (© 2019 John Wiley & Sons Ltd.)

Details

Language :
English
ISSN :
1365-2265
Volume :
92
Issue :
2
Database :
MEDLINE
Journal :
Clinical endocrinology
Publication Type :
Academic Journal
Accession number :
31715012
Full Text :
https://doi.org/10.1111/cen.14127